These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11191929)

  • 1. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
    Bostantjopoulou S; Katsarou Z; Zafiriou D; Gerasimou G; Alevriadou A; Georgiadis G; Kiosseoglou G; Kazis A
    Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
    J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
    Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
    Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
    Rossini PM; Bassetti MA; Pasqualetti P
    Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components.
    Rossini PM; Traversa R; Boccasena P; Martino G; Passarelli F; Pacifici L; Bernardi G; Stanzione P
    Neurology; 1993 Dec; 43(12):2495-500. PubMed ID: 8255446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine sulfate infusion effect on N30 somatosensory evoked potentials in Parkinson's disease.
    Bostantjopoulou S; Katsarou Z; Georgiadis G; Zafiriou D; Kazis A
    Clin Neuropharmacol; 2002; 25(2):115-8. PubMed ID: 11981240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
    Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
    Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.
    Abe Y; Kachi T; Kato T; Arahata Y; Yamada T; Washimi Y; Iwai K; Ito K; Yanagisawa N; Sobue G
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):419-22. PubMed ID: 12640053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes.
    Pierantozzi M; Sabato AF; Leonardis F; Marciani MG; Cicardi C; Giacomini P; Bernardi G; Stanzione P
    Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease.
    Garcia PA; Aminoff MJ; Goodin DS
    Neurology; 1995 May; 45(5):989-92. PubMed ID: 7746421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and
    Yoshida T; Mori T; Shimizu H; Yoshino Y; Sonobe N; Matsumoto T; Kikuchi K; Miyagawa M; Iga J; Mochizuki T; Ueno SI
    Int J Geriatr Psychiatry; 2017 Apr; 32(4):407-413. PubMed ID: 27094214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence between short-latency somatosensory evoked brain potentials and cortical magnetic fields following median nerve stimulation.
    Hoshiyama M; Kakigi R
    Brain Res; 2001 Jul; 908(2):140-8. PubMed ID: 11454324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease.
    Drory VE; Inzelberg R; Groozman GB; Korczyn AD
    Acta Neurol Scand; 1998 Feb; 97(2):73-6. PubMed ID: 9517855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
    Mauguière F; Broussolle E; Isnard J
    Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of somatosensory evoked potentials in spasmodic torticollis.
    Mazzini L; Zaccala M; Balzarini C
    Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N30 component of somatosensory evoked potentials in patients with dystonia.
    Reilly JA; Hallett M; Cohen LG; Tarkka IM; Dang N
    Electroencephalogr Clin Neurophysiol; 1992; 84(3):243-7. PubMed ID: 1375883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD.
    Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N
    Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
    Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
    J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients.
    Rossini PM; Babiloni F; Bernardi G; Cecchi L; Johnson PB; Malentacca A; Stanzione P; Urbano A
    Electroencephalogr Clin Neurophysiol; 1989; 74(4):277-89. PubMed ID: 2471629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of the basal ganglia in the generation of the N30 potential of the median nerve somatosensory evoked potentials.
    Beniczky S; Nagy H; Varga E; Vörös E; Kéri S; Vécsei L
    Ideggyogy Sz; 2007 Sep; 60(9-10):392-7. PubMed ID: 17987733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.